By Health In Five
Union Minister for Chemicals and Fertilizers, DV Sadananda Gowda has said India is one of the largest manufacturers and exporters of generic medicines across the world. During initial phase, he said, HCQ and Azithromycin was identified as one of medicines under treatment protocol for covid-19 in emergency cases. Referring to India supplying these medicines to more than 120 countries across the world; he underlined that india thereby earned the reputation of reliable supplier of medicines.
Addressing the virtual Latin America & Caribbean session on ‘Reimagining Distances’, during LEADS 2020, organised by FICCI recently, Gowda said that Indian pharma sector can grow to $ 65 billion industry by 2024. “We have recently launched schemes for development of seven mega parks—three bulk drug parks and four medical devices parks across country. New manufacturers will be eligible for Production Linked Incentive (PLI) Scheme under which they will be eligible for financial incentives on basis of their sales for first 5-6 years,” Gowda said.
The Minister further emphasised that this is a very- very good time to invest, and set up manufacturing base in India in pharma sector. “One can enter India market through Joint Ventures also. The advantage is that you can get access to big markets like domestic Indian market, US, Japan, EU and South East Asia through India as far as pharma sector is concerned. Any body can contact my office if they are interested in Indian pharma sector, we will provide all possible facilitation and hand holding,” he stressed.
Gowda also said that the market size of Chemicals & Petrochemicals sector in India is around 165 billion dollars. The size is expected to grow up to 300 billion dollars by 2025. This presents a huge opportunity in Chemical sector India. For example, to meet the growing demand India will need 5 crackers by 2025 and additional 14 by 2040. These crackers alone will require cumulative investment of 65 billion dollar. To attract foreign participation, he said, Government of India is revisiting policies for chemical and petrochemical sector. “We are thinking to extend financial incentive based on sales similar to what is being extended in our pharmaceutical sector. We are also tweaking our policies to strengthen our chemical industrial cluster which we call as PCPIRs and plastic parks. Together, these supportive Government policies will offer one of the best environments to do business in India as far as chemicals & petrochemical sector is concerned,” Gowda said.
“We would welcome any proposal in these sectors and extend all possible handholding in India wherever it will be required, he assured,” he added.